SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation

Por Casini, Nadia, Forte, Iris Maria, Mastrogiovanni, Gianmarco, Pentimalli, Francesca, Angelucci, Adriano, Festuccia, Claudio, Tomei, Valentina, Ceccherini, Elisa, Di Marzo, Domenico, Schenone, Silvia, Botta, Maurizio, Giordano, Antonio, Indovina, Paola
Publicado no Oncotarget (2015)